Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM EBITDA Multiple | 24,6x - 27,2x | 25,9x |
Selected Fwd EBITDA Multiple | 70,1x - 77,5x | 73,8x |
Fair Value | ₩135,72 - ₩170,41 | ₩153,06 |
Upside | -47,0% - -33,4% | -40,2% |
Benchmarks | Ticker | Full Ticker |
Icure Pharmaceutical Incorporation | A175250 | KOSDAQ:A175250 |
HuM&C Co., Ltd. | A263920 | KOSDAQ:A263920 |
HLscience Co., Ltd. | A239610 | KOSDAQ:A239610 |
Outin Futures Co., Ltd | A227610 | KOSDAQ:A227610 |
Hankook Cosmetics Co., Ltd. | A123690 | KOSE:A123690 |
TS Trillion Co., Ltd. | A317240 | KOSDAQ:A317240 |
- | - | - |
Select LTM EBITDA Multiple | |||||||
Benchmark Companies | |||||||
A175250 | A263920 | A239610 | A227610 | A123690 | A317240 | ||
KOSDAQ:A175250 | KOSDAQ:A263920 | KOSDAQ:A239610 | KOSDAQ:A227610 | KOSE:A123690 | KOSDAQ:A317240 | ||
Historical EBITDA Growth | |||||||
5Y CAGR | NM- | NM- | NM- | NM- | NM- | -25.7% | |
3Y CAGR | NM- | 95.0% | NM- | NM- | 46.4% | NM- | |
Latest Twelve Months | 50.7% | -17.8% | -199.8% | -202.2% | 12.2% | 2.0% | |
Historical EBITDA Profit Margin | |||||||
5 Year Average Margin | -23.7% | -7.8% | -3.0% | -14.7% | -0.4% | -1.5% | |
Prior Fiscal Year | -32.9% | 17.6% | -9.5% | 4.8% | 6.4% | 3.8% | |
Latest Fiscal Year | -13.3% | 14.9% | -41.3% | -4.6% | 6.0% | 5.1% | |
Latest Twelve Months | -13.3% | 14.9% | -41.3% | -4.6% | 6.0% | 5.1% | |
Current Trading Multiples | |||||||
EV / LTM Revenue | 1.32x | 1.23x | 1.42x | 1.34x | 1.07x | 1.62x | |
EV / LTM EBITDA | -9.9x | 8.2x | -3.4x | -29.1x | 17.7x | 31.8x | |
EV / LTM EBIT | -5.1x | 10.8x | -2.5x | -13.6x | 26.5x | 182.3x | |
Low | Mid | High | |||||
Benchmark EV / LTM EBITDA | -29.1x | -3.4x | 17.7x | ||||
Historical EV / LTM EBITDA | -109.5x | -29.8x | 31.8x | ||||
Selected EV / LTM EBITDA | 24.6x | 25.9x | 27.2x | ||||
(x) LTM EBITDA | 1,566 | 1,566 | 1,566 | ||||
(=) Implied Enterprise Value | 38,565 | 40,595 | 42,625 | ||||
(-) Non-shareholder Claims * | (21,429) | (21,429) | (21,429) | ||||
(=) Equity Value | 17,137 | 19,166 | 21,196 | ||||
(/) Shares Outstanding | 110.5 | 110.5 | 110.5 | ||||
Implied Value Range | 155.05 | 173.42 | 191.78 | ||||
FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
Implied Value Range (Trading Cur) | 155.05 | 173.42 | 191.78 | 256.00 | |||
Upside / (Downside) | -39.4% | -32.3% | -25.1% |
Equity Waterfall | |||||||
Benchmark Companies | |||||||
(in millions) | A175250 | A263920 | A239610 | A227610 | A123690 | A317240 | |
Enterprise Value | 91,273 | 57,858 | 24,742 | 46,497 | 98,091 | 49,722 | |
(+) Cash & Short Term Investments | 22,437 | 6,180 | 26,868 | 8,129 | 16,336 | 4,807 | |
(+) Investments & Other | 1,659 | 7 | 10,751 | 1,611 | 5,437 | 500 | |
(-) Debt | (40,440) | (13,332) | (450) | (23,526) | (6,545) | (26,736) | |
(-) Other Liabilities | (472) | 0 | (82) | 2,312 | (63) | 0 | |
(-) Preferred Stock | (2,707) | 0 | 0 | 0 | 0 | 0 | |
(-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
Value of Common Equity | 71,750 | 50,713 | 61,828 | 35,023 | 113,257 | 28,293 | |
(/) Shares Outstanding | 37.4 | 49.0 | 5.1 | 35.4 | 16.1 | 110.5 | |
Implied Stock Price | 1,920.00 | 1,034.00 | 12,140.00 | 988.00 | 7,050.00 | 256.00 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 1,920.00 | 1,034.00 | 12,140.00 | 988.00 | 7,050.00 | 256.00 | |
Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |